Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Update

Enzolytics, Inc. (OTCMKTS:ENZC) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 1,800 shares, a drop of 99.6% from the February 28th total of 499,900 shares. Based on an average daily volume of 7,236,000 shares, the days-to-cover ratio is presently 0.0 days.

Enzolytics Price Performance

Shares of ENZC stock opened at $0.00 on Thursday. Enzolytics has a 12 month low of $0.00 and a 12 month high of $0.01.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.